인간 트롬빈 시장 조사 – 규모, 점유율, 개발 및 미래 범위 2031

  • Report Code : TIPRE00008178
  • Category : Life Sciences
  • No. of Pages : 150
지금 구매

시장 소개

트롬빈은 F2라는 특정 유전자에 의해 인코딩되는 세린 프로테아제 효소이며 가용성 피브리노겐을 불용성 피브린으로 전환하는 데 사용됩니다. 인간 트롬빈은 pH 6.8-7.2의 멸균 용액으로 응고 활성화를 위한 고도로 정제된 인간 트롬빈을 함유하고 있습니다. 조절되지 않는 출혈을 관리하는 다양한 의료 수술에 사용됩니다. R&D 애플리케이션에는 단백질 구조 분석, 체외 연구, 응고 연구, 생화학 연구, 의학 연구 등 여러 연구 활동이 포함됩니다.

시장 역학

인간 트롬빈 시장은 다양한 연구 및 진단 응용 분야에서 채택이 증가할 것으로 예상됩니다. 그러나 수술 중 트롬빈 기반 제품의 지혈 사용이 증가함에 따라 병원 부문에서 트롬빈에 대한 수요가 증가했습니다. 또한, 수술 중 과도한 출혈에 대한 지혈제 채택이 늘어나면서 예측 기간 동안 시장 성장에 도움이 될 것으로 예상됩니다.

시장 범위

"2031년까지의 인간 트롬빈 시장 분석"은 글로벌 시장 동향 분석에 특별히 초점을 맞춘 의료 산업에 대한 전문적이고 심층적인 연구입니다. 이 보고서는 제품, 제형, 최종 사용자 및 지역별로 상세한 시장 세분화를 통해 인간 트롬빈 시장에 대한 개요를 제공하는 것을 목표로 합니다. 인간 트롬빈 시장은 예측 기간 동안 높은 성장을 보일 것으로 예상됩니다. 이 보고서는 인간 트롬빈 시장 선두 기업의 시장 상태에 대한 주요 통계를 제공하고 시장의 주요 추세와 기회를 제공합니다.

시장 세분화

인간 트롬빈 시장은 제품, 제형 및 최종 사용자를 기준으로 분류됩니다. 제품에 따라 시장은 소 트롬빈, 인간 트롬빈 및 재조합 트롬빈으로 분류됩니다. 제형에 따라 시장은 분말형, 용액형 등으로 분류됩니다. 최종 사용자를 기준으로 시장은 병원, 진단 센터 및 시장으로 분류됩니다. 진료소, 학계, 연구 기관.

< /strong>

이 보고서는 다음을 포함한 업계에 대한 자세한 개요를 제공합니다. 질적 정보와 양적 정보 모두. 다양한 부문을 기반으로 인간 트롬빈 시장에 대한 개요 및 예측을 제공합니다. 또한 5개 주요 지역에 대해 2021년부터 2031년까지 시장 규모와 예측 추정치를 제공합니다. 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA) 및 남부 & 중앙 아메리카. 각 지역별 인간 트롬빈 시장은 나중에 각 국가 및 부문별로 세분화됩니다. 이 보고서는 전 세계 18개국에 대한 분석 및 예측과 함께 이 지역에 만연한 현재 동향 및 기회를 다룹니다.

이 보고서는 수요와 공급 측면 모두에서 인간 트롬빈 시장에 영향을 미치는 요인을 분석하고 예측 기간 동안 시장에 영향을 미치는 시장 역학, 즉 동인, 제약, 기회 및 미래 추세를 추가로 평가합니다. 이 보고서는 또한 5개 지역 모두에 대한 철저한 PEST 분석을 제공합니다. 북미, 유럽, APAC, MEA 및 남부 & 중앙 아메리카 지역의 인간 트롬빈 시장에 영향을 미치는 정치적, 경제적, 사회적 및 기술적 요인을 평가한 후.


시장 플레이어

이 보고서는 유기 및 무기 성장 전략으로서 인간 트롬빈 시장의 주요 발전을 다루고 있습니다. 다양한 기업들이 제품 출시, 제품 승인, 특허, 이벤트 등 유기적인 성장 전략에 주력하고 있습니다. 시장에서 목격된 무기적 성장 전략은 인수, 파트너십 & 협력. 이러한 활동은 시장 참가자의 비즈니스 및 고객 기반 확장을 위한 길을 열었습니다. 인간 트롬빈 시장의 시장 참가자들은 세계 시장에서 인간 트롬빈 시장에 대한 수요가 증가함에 따라 미래에 수익성 있는 성장 기회를 가질 것으로 예상됩니다. 아래에는 인간 트롬빈 시장에 참여하는 몇몇 회사의 목록이 나와 있습니다.

이 보고서에는 SWOT 분석 및 시장 전략과 함께 인간 트롬빈 시장 기업의 주요 프로필도 포함되어 있습니다. 또한 이 보고서는 회사 프로필, 제공된 구성 요소 및 서비스, 지난 3년간의 재무 정보, 지난 5년간의 주요 개발과 같은 정보를 제공하는 업계 선두 기업에 중점을 두고 있습니다.

     AMRESCO Inc. Baxter International, Inc.   ;바이엘 AG BD Biosciences CSL Behring Life Technologies Corporation Pfizer Inc. PromoCell GmbH Sigma-Aldrich Corporation Vitrolife AB
Insight Partner의 전담 연구 및 분석 팀은 고급 통계 전문 지식을 갖춘 숙련된 전문가로 구성되어 있으며 기존 연구에서 다양한 사용자 정의 옵션을 제공합니다.
  • 역사적 분석(2년), 기준 연도, CAGR을 포함한 예측(7년)
  • PEST 및 SWOT 분석
  • 시장 규모 가치/양 - 글로벌, 지역, 국가
  • 산업 및 경쟁 환경
  • Excel 데이터 세트
human-thrombin-market-report-deliverables-img1
human-thrombin-market-report-deliverables-img2
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

자주 묻는 질문


Which are the leading players operating in the Human Thrombin Market?

The leading players of the market are: AMRESCO Inc., Baxter International, Inc., Bayer AG, BD Biosciences, CSL Behring, Life Technologies Corporation, Pfizer Inc., PromoCell GmbH, Sigma-Aldrich Corporation, Vitrolife AB

What are the deliverable formats of the Human Thrombin Market report?

The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.

What are the options available for the customization of this report? 

Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.

What are the future trends of the Human Thrombin Market?

Increasing adoption of minimally invasive surgical techniques that often require precise and rapid hemostasis. Human thrombin is the preferred agent in these procedures due to its potent acceleration of clot formation. Also, the latest developments in biotechnology and recombinant DNA technology are facilitating the development of newer thrombin formulations with better efficacy and safety profiles. The rising incidence of chronic diseases and geriatric patients with age-related bleeding disorders will continue to elevate demand for human thrombin. Additionally, a rise in point-of-care testing and personalized medicine applications could lead to the development of novel diagnostic and therapeutic applications for human thrombin. With the continued evolution of the healthcare industry, human thrombin can be expected to make its mark on several clinical needs.

What is the expected CAGR of the Human Thrombin Market?

Human Thrombin Market is expected to grow at a CAGR of 4.8% between 2023-2031

What are the driving factors impacting the Human Thrombin Market?

The primary driving forces for the Human Thrombin Market are several factors. First, this market is driven by an increase in the number of surgical procedures, which are especially minimally invasive. In such cases, human thrombin is essential to ensure effective hemostasis. Age is another factor; the vulnerable section due to bleeding disorders requires comparatively more thrombin-based treatment. The increasing development of medical technology and new formulations of thrombin have also constituted the factors for the growth of this market. The growing awareness of the benefits of rapid hemostasis and reduced blood loss also will fuel the demand for human thrombin in various clinical settings. On the other hand, the promising trends driving the future of the Human Thrombin Market include several emerging ones as discussed below.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies

1. AMRESCO Inc.
2. Baxter International, Inc.
3. Bayer AG
4. BD Biosciences
5. CSL Behring
6. Life Technologies Corporation
7. Pfizer Inc.
8. PromoCell GmbH
9. Sigma-Aldrich Corporation
10. Vitrolife AB
human-thrombin-market-cagr

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.